Edition:
United States

OHR Pharmaceutical Inc (OHRP.OQ)

OHRP.OQ on NASDAQ Stock Exchange Capital Market

0.18USD
4:00pm EDT
Change (% chg)

$0.00 (+2.22%)
Prev Close
$0.18
Open
$0.18
Day's High
$0.19
Day's Low
$0.18
Volume
35,898
Avg. Vol
76,531
52-wk High
$2.17
52-wk Low
$0.15

Chart for

About

Ohr Pharmaceutical, Inc. is a pharmaceutical company focused on the development of therapeutics and delivery technologies for the treatment of ocular disease. The Company's development pipeline consists of several programs and indications at various stages of development. Its product pipeline includes Squalamine Lactate... (more)
No analyst recommendations are available for .

Overall

Beta: 0.36
Market Cap(Mil.): $39.03
Shares Outstanding(Mil.): 56.21
Dividend: --
Yield (%): --

Financials

  OHRP.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.70 -- --
ROI: -88.21 1.78 14.61
ROE: -88.44 3.27 16.33

BRIEF-OHR Pharmaceutical Q2 Loss Per Share $0.04

* OHR PHARMACEUTICAL REPORTS FISCAL SECOND QUARTER 2018 FINANCIAL RESULTS

May 15 2018

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF235.05 -1.45
Roche Holding Ltd. (RO.S) CHF236.60 -2.00
Regeneron Pharmaceuticals Inc (REGN.OQ) $387.25 +3.55
Amgen, Inc. (AMGN.OQ) $205.10 +1.90
Novartis AG (NOVN.S) CHF81.94 +0.20
Allergan plc (AGN.N) $192.51 +4.48

Earnings vs. Estimates